Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-432,174
Closed -$6.67M 400
2023
Q3
$6.67M Sell
432,174
-937
-0.2% -$15.7K 0.09% 262
2023
Q2
$8.21M Buy
433,111
+131,530
+44% +$2.31M 0.1% 237
2023
Q1
$4.59M Buy
+301,581
New +$3.93M 0.06% 299

Other funds holding ETNB

Driehaus Capital Management's ETNB Position: Q4 2023 in Review

Driehaus Capital Management sold out of 89bio (ETNB) in Q4 2023, closing a stake of 432,174 shares — an estimated $6.67M sold.

Driehaus Capital Management first reported a position in ETNB in Q1 2023 and held it in 3 quarters. The position peaked at $8.21M in Q2 2023. 153 funds tracked by Wall St. Rank hold ETNB as of Q4 2023.

  • Driehaus Capital Management reported no remaining 89bio position as of Q4 2023 after selling out during the quarter.
  • Driehaus Capital Management sold 432,174 89bio shares in Q4 2023, an estimated $6.67M.
  • Driehaus Capital Management first reported a position in 89bio in Q1 2023 and held it in 3 quarters.
  • Driehaus Capital Management's 89bio position peaked at $8.21M in Q2 2023.
  • 153 funds tracked by Wall St. Rank held 89bio as of Q4 2023.

Based on Driehaus Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.